Ryan Woodman, D.O.

Ryan Woodman, D.O.

Specialties

Endocrinology

Department

Internal Medicine

Title

  • Associate Physician

Reviews

To see if Ryan Woodman is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Clinical Interests

Dr. Woodman is an endocrinologist who cares for individuals with endocrine disorders. He has a clinical interest in gonadal dysfunction, andrology, LGBT+ care, bone/calcium disorders, and obesity and metabolic health.

Research/Academic Interests

Dr. Woodman's research focuses on understanding how environmental and genetic influences affect diseases. Specifically, examining the contribution of alpha-2 adrenergic receptor signaling to the deleterious metabolic, gonadal, and behavioral effects found in stressed states, such as post-traumatic stress disorder and traumatic brain injury. He also has an interest in human performance and translation research.

Division

Endocrinology, Diabetes, and Metabolism

Education

D.O., Kansas City University, Kansas City MO 2012

B.S., UC San Diego, San Diego CA 2005

Internship: Internal Medicine, University of Missouri School of Medicine, Columbia MO 2012-2013

Residency

Internal Medicine, University of Missouri School of Medicine, Columbia MO 2013-2015

Fellowships

Endocrinology, University of Missouri School of Medicine, Columbia MO 2016-2018

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism,

Honors and Awards

Basic Science Research Award, Kansas City University, 2012

Select Recent Publications

Woodman R, Student J, Miller C, Lockette W. Ivabradine reduces adverse cognitive and behavioral responses following traumatic stress. Submitted, 2019

Woodman R, Student J, Malcolm T, Lockette W. Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: a treatment for emotional eating? Submitted, 2019

Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56(3):463-470.

Watson R, Woodman R, Lockette W. Ephedra alkaloids inhibit platelet aggregation. Blood Coagul Fibrinolysis. 2010;21(3):266-271.

Woodman R, Lockette W. Alpha-methyltyrosine inhibits formation of reactive oxygen species and diminishes apoptosis in PC12 cells. Brain Res. 2009;1296:137-147.